About us

About us

Team

Development of joint preserving surgical procedures is of paramount importance for ArthroSave. Our company is the continuation from years of academic research, in which we worked hard to solve the mobility issues for younger patients with knee osteoarthritis.

Years of experience with knee joint distraction in scientific coordinated trials resulted in a potent additional form of joint preserving treatment. Furthermore, in an academic setting, ArthroSave developed the KneeReviver distractor to further refine knee joint distraction treatment.

Since 2018 we have a business office located in Culemborg. After a successful launch of the KneeReviver in selected hospitals in the Netherlands we also export the KneeReviver to Belgium, United Kingdom, Switzerland and Germany.

The team consists of:

Karianne Lindenhovius

Chief Executive Officer
Co-founder and responsible for business strategy, team building, and attracting financing.

Peter van Roermund

Medical Officer
Co-founder, orthopedic surgeon, and inventor of joint distraction, with an extensive clinical network and responsible for the surgical technique.

Timo van Dienst

Chief Commercial Officer
Head of commercial operations and responsible for international market access of the KneeReviver.

Lars Ottevanger

Chief Financial Officer
Financial expert managing our daily finances and our long-term financing strategy.

José Lugies

Product Specialist Orthopaedics
With extensive knowledge of the KneeReviver, she introduces our innovative solution into the clinical field.

Jeroen Mol

Project Manager Medical Device Development
Driving innovation in joint preservation through strategic, clinical, and digital leadership in medical device development.

Paulien van Leeuwen

Product Specialist Orthopaedics
With extensive knowledge and experience in orthopaedics as a Physiotherapist and Medical Devices Account Manager, she introduces our innovative solution, the KneeReviver, into the clinical field.

Jobs

History

  • First knee joint distraction treatment in medical research group.
  • Winner Ureka Mega Challenge.
  • Start development KneeReviver in valorisation process UMC Utrecht.
  • KneeReviver has potential. Start ArthroSave as spin-off company UMC Utrecht.
  • First KneeReviver treatment in NL.
  • First KneeReviver treatments outside NL, in Europe.
  • ArthroSave winner of Academic Startup Competition, present at GES2019, participant in Incubator program in Silicon Valley USA.
  • ArthroSave supplier of Reimbursement trial (GODIVA)

ArthroSave is a spin-off of UMC Utrecht

ArthroSave can rely on a valuable network of partners